Relief Therapeutics Holding AG (RLFTF)

[smm886]

Why announce results while there's distribution questions up in the air? You have to remember that as an investor, your bias leads you to believe that the best course of action is what will affect the stock price in the short term. As business people, NeuroRX / Relief / Glaxo are all looking at this in much longer horizons (1 year, 3 year, 10 year) and all the uses for it. The long game is that you answer any and all outstanding questions (distribution capabilities, outstanding shares, financing structure, marketing announcements) before you drop trial data. The best path to success is one not filled with ammunition for naysayers

STAY RESILIENT